ICU superbug study aims to protect vulnerable patients

NCT ID NCT06652126

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will observe 1,000 critically ill patients in European ICUs to see if those with weakened immune systems are more or less likely to pick up drug-resistant bacteria. Researchers want to understand if current isolation measures are working and how to better control the spread of these dangerous germs. The goal is to improve antibiotic use and infection prevention for all ICU patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICALLY ILL PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • chu de Lille

    RECRUITING

    Lille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.